Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Cash from Financing Activities: 2013-2025

Historic Cash from Financing Activities for MediWound (MDWD) over the last 11 years, with Sep 2025 value amounting to $30.5 million.

  • MediWound's Cash from Financing Activities rose 47.40% to $30.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.2 million, marking a year-over-year increase of 53.27%. This contributed to the annual value of $19.4 million for FY2024, which is 15.37% down from last year.
  • Per MediWound's latest filing, its Cash from Financing Activities stood at $30.5 million for Q3 2025, which was up 5,460.11% from $549,000 recorded in Q2 2025.
  • MediWound's 5-year Cash from Financing Activities high stood at $30.5 million for Q3 2025, and its period low was -$728,000 during Q2 2022.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$204,000 (2023), whereas its average is $6.6 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 808.00% in 2021, then spiked by 8,370.06% in 2022.
  • Over the past 5 years, MediWound's Cash from Financing Activities (Quarterly) stood at -$177,000 in 2021, then surged by 8,370.06% to $14.6 million in 2022, then crashed by 101.39% to -$204,000 in 2023, then plummeted by 151.47% to -$513,000 in 2024, then surged by 47.40% to $30.5 million in 2025.
  • Its Cash from Financing Activities stands at $30.5 million for Q3 2025, versus $549,000 for Q2 2025 and -$362,000 for Q1 2025.